P688: ASC2ESCALATE: A US PHASE 2, OPEN-LABEL, SINGLE-ARM, DOSE-ESCALATION STUDY OF ASCIMINIB MONOTHERAPY IN 2ND-LINE (2L) TREATMENT OF PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)

Detalles Bibliográficos
Autores principales: Atallah, Ehab, Mauro, Michael, Sasaki, Koji, Yair Levy, Moshe, Koller, Paul, Sadek, Islam, Yang, Daisy, Ruckel-Kumar, Julie, Khan, Mahmudul, Cortes, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428989/
http://dx.doi.org/10.1097/01.HS9.0000969656.81442.84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428989/
http://dx.doi.org/10.1097/01.HS9.0000969656.81442.84

Ejemplares similares